Lack of relationship of angiotensinogen gene m235t polymorphism and ace gene insertion/deletion (i/d - intron 16) and pst i rflp (p/m - intron 7) polymorphisms in the development of h-gestosis. Preliminary results;Brak zwia̧zku polimorfizmu m235t genu angiotensynogenu i polimorfizmów insercja/delecja (i/d - intron 16) oraz pst i rflp (p/m - intron 7) genu enzymu konwertuja̧cego angiotensynȩ i (ace) z wystȩpowaniem h-gestozy. Doniesienie wstȩpne

Polskie Archiwum Medycyny Wewnetrznej

Volumn 100, Issue 1, 1998, Pages 19-26

  Nałogowska Głośnicka, Krystyna ^a   Ła̧cka, Beata ^a   Zychma, Margin ^a   Grzeszczak, Władysław ^a   Michalski, Bogdan ^b   Porȩba, Ryszard ^b   Kniazewski, Bartosz ^c   Rzempołuch, Jacek ^c  

^a Kat i Klinika Chorob W   (Poland)

^b IV Kat i Klinika Poloznictwa i G   (Poland)

^c I Kat i Klinika P

Author keywords

ACE gene I D polymorphism; Angiotensinogen gene m235t polymorphism; H gestosis; Pst I RFLP polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INTRON; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRONS; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRE-ECLAMPSIA; PREGNANCY; SEQUENCE DELETION;

EID: 0032106329     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. National high blood pressure education working group resort on high blood pressure in pregnancy. Am. J. Obster. Gynecol., 1990, 163, 1691.
2. Sibai B.M.: Treatment of hypertension in pregnant women. Drug Therapy, 1996, 335, 257.
3. August P., Sealey J.E.: The renin-angiotensin system in normal and hypertensive pregnancy and in ovarian function. W: Hypertension: Pathophysiology, Diagnosis and Management (ed.: Laragh J.H., Brenner B.M. 1761 (Raven, New York 1990).
4. Chesley L.C., Cosgrove R.A., Annitto J.E.: Pregnancy in the sisters and daughters of eclamptic women. Path. Microbiol., 1961, 24, 662.
5. Nova A., Sibai B.M., Barton J.R. i wsp.: Maternal plasma level of endothelin is increased in pre-eclampsia. Am. J. Obstet. Gynecol., 1991, 165, 724.
6. Uotila J.T., Tuimala R.J., Aarnio T.M.: Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. Br. J. Obstet. Gynaecol., 1993, 100, 270.
7. Wisdom S.J., Wilson R., McKillop J.H. i wsp.: Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am. J. Obstet. Gynecol., 1991, 165, 1701.
8. Fitzgerald D.J., Roscki W., Murray R. i wsp.: Thromboxane A2 synthesis in pregnancy induced hypertension. Lancet, 1990, 335, 751.
9. Walsh S.W.: Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am. J. Obstet. Gynecol., 1985, 152, 335.
10. Roberts J.M., Taylor R.N., Musci T.J. i wsp.: pre-eclampsia: An endothelial cell disorder. Am. J. Obstet. Gynecol., 1989, 161, 1200.
11. Arngrimsson R., Hayward C., Nadaud S. i wsp.: Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am. J. Hum. Genet., 1997, 61, 354.
12. Liston W.A., Kilpatrick D.: Is genetic susceptibility to pre-eclampsia confered by homozygosity for the same single recessive gene in mother and fetus? Br. J. Obstet. Gynecol., 1991, 98, 1079.
13. Kilpatrick D.C., Liston W.A., Gibson F. i wsp.: Association between susceptibility to pre-eclampsia within families and HLA-DR4. Lancet, 1989, 2, 1063.
14. Arngrimsson R., Bjornsson S., Geirsson R.T. i wsp.: Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br. J. Obstet. Gynecol., 1990, 97, 762.
15. Chesley L.C., Cooper D.W.: Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br. J. Obstet. Gynecol., 1986, 93, 899.
16. Cooper D.W., Hill J.A., Chesley L.C. i wsp.: Genetic control of susceptibility to eclampsia and miscarriage. Br. J. Obstet. Gynecol., 1988, 95, 644.
17. Humphrey K.E., Harrison G.A., Cooper D.W. i wsp.: HLA-G deletion polymorphism and pre-eclampsia/eclampsia. Br. J. Obstet. Gynecol., 1995, 102, 707.
18. Wilton A.N., Cooper D.W., Brennecke S.P. i wsp.: Absence of close linkage between maternal genes for susceptibility to pre-eclampsia/eclampsia and HLA-DR beta. Lancet, 1990, 336, 653.
19. Chen G., Wilson R., Wang S.H. i wsp.: Tumor necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin. Exp. Immunol., 1996, 104, 154.
20. Harrison G.A., Humphrey K.E., Jones N. i wsp.: A genomewide linkage study of preeclampsia/eclampsia reveals evidence a candidate region on 4q. Am. J. Hum. Genet., 1997, 60, 1158.
21. Arngrimsson R., Geirsson R.T., Cooke A. i wsp.: Renin gene restriction fragment length polymorphism do not show linkage with pre-eclampsia and eclampsia. Acta Obstet. Gynecol. Scand., 1994, 73, 10.
22. Kobashi G.: A case-control study of pregnancy-induced hypertension with a genetic predistposition: association of a molecular variant of angiotensinogen in the Japanese women. (Japanese, abstract in English). Hokkaido Igaku Zasshi, 1995, 70, 649.
23. Ward K., Hata A., Jeunemaitre X. i wsp.: A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet., 1993, 4, 59.
24. Arngrimsson R.R., Purandare S., Connor M. i wsp.: Angiotensionogen. a candidate gene involved in preeclampsia? Nature Genet., 1993, 4, 114.
25. Coulfield M., Lavender P., Farrall M. i wsp.: Linkage of the angiotensinogen gene to essential hypertension. N. Engl. J Med., 1994, 330, 1629.
26. Gerbase-De Lima M., ladalardo M.A., Galvao DeLima J.J. i wsp.: Essential hypertension and histocompatibility antigens. An association study. Hypertension, 1992, 19, 400.
27. Grzeszezak W., Zychma M., Żukowska-Szczechowska E i wsp.: Czy polimorfizm Pst I genu enzymu konwertuja̧cego ła̧czy siȩ ze zwiȩkszonym ryzykiem zapadalności na nefropatiȩ u chorych na cukrzycȩ insulino-niezależna̧ (doniesienie wstȩpne). Pol. Arch. Med. Wewn., 1997, 98, 19.
28. Karasek D., Zychma M., Grzeszczak W. i wsp.: Angiotensinogen m235t polymorphism and chronic renal failure in polycystic kidney disease (ADPKD) (case-control study) (preliminary results). Ann. Acad. Med. Gedan , 1997, 27, supl. 2, 115.
29. Zychma M., Grzeszczak W., Żukowska-Szczechowska E. i wsp.: Angiotensin converting enzyme gene (I/D) polymorphism does not contribute to the development of chronic renal failure in polycystic kidney disease (ADPKD) (case-control study) (preliminary results). Ann. Acad. Med. Gedan., 1997, 27, supl. 2, 125.
30. Ness R.B., Roberts J.M.: Heterogenous causes constituting the single syndrom of preeclampsia: A hypothesis and its implications. Am. J. Obstet. Gynecol., 1996, 175, 1365.
31. Jeunemaitre X., Soubrier F., Kotelvtsev Y.V. i wsp.: Molecular basis of human hypertension: role of angiotensinogen. Cell, 1992, 71, 169.
32. Morgan L., Baker P., Broughton F. i wsp.: Pre-eclampsia and the angiotensinogen gene. Br. J. Obstet. Gynecol., 1995, 102, 489.
33. Tamura T., Johanning G.L., Goldenberg R. i wsp.: Effect of angiotensin-converting enzyme gene polymorphism in pregnancy outcome, enzyme activity and zinc concentration. Obstet. Gynecol., 1996, 88, (4 Pt 1), 497.
34. Wolff K., Faxen M., Lunell N.O. i wsp.: Endothelin receptor type A and B gene expression in human non-pregnant, term pregnant, and preeclamptic uterus. Am. J. Obstet. Gynecol., 1996, 175, 1295.